Can CDK4/6 inhibitors cause fatal lung injury?

被引：36
|
作者：
Jazieh, Khalid A. [1 ]
Budd, G. Thomas [2 ]
Dalpiaz, Nancy [2 ]
Abraham, Jame [2 ]
机构：
[1] Cleveland Clin Fdn, Dept Internal Med, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Taussig Canc Ctr, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2019年 / 19卷 / 11期
关键词：
Breast Cancer; Palbociclib; Abemaciclib; Pneumonitis; Toxicity; PALBOCICLIB; PNEUMONITIS; CANCER; RISK;
D O I：
10.1080/14737140.2019.1674651
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：917 / 919
页数：3
相关论文
共 50 条
  • [31] Development of CDK4/6 Inhibitors: A Five Years Update
    Ammazzalorso, Alessandra
    Agamennone, Mariangela
    De Filippis, Barbara
    Fantacuzzi, Marialuigia
    MOLECULES, 2021, 26 (05):
  • [32] Predicting Response to CDK4/6 Inhibitors in Breast Cancer
    Schultz, Emily
    Hamilton, Deanna
    Wang, Jianxin
    Witkiewicz, Agnieszka
    LABORATORY INVESTIGATION, 2023, 103 (03) : S208 - S208
  • [33] CDK4/6 inhibitors in breast cancer: spotting the difference
    Perez-Garcia, Jose Manuel
    Cortes, Javier
    Llombart-Cussac, Antonio
    NATURE MEDICINE, 2021, 27 (11) : 1868 - 1869
  • [34] CDK4/6 inhibitors: a novel strategy for tumor radiosensitization
    Yang, Yilan
    Luo, Jurui
    Chen, Xingxing
    Yang, Zhaozhi
    Mei, Xin
    Ma, Jinli
    Zhang, Zhen
    Guo, Xiaomao
    Yu, Xiaoli
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [35] Senescence as a therapeutically relevant response to CDK4/6 inhibitors
    Wagner, Verena
    Gil, Jesus
    ONCOGENE, 2020, 39 (29) : 5165 - 5176
  • [36] Senescence as a therapeutically relevant response to CDK4/6 inhibitors
    Verena Wagner
    Jesús Gil
    Oncogene, 2020, 39 : 5165 - 5176
  • [37] CDK4/6 inhibitors: a novel strategy for tumor radiosensitization
    Yilan Yang
    Jurui Luo
    Xingxing Chen
    Zhaozhi Yang
    Xin Mei
    Jinli Ma
    Zhen Zhang
    Xiaomao Guo
    Xiaoli Yu
    Journal of Experimental & Clinical Cancer Research, 39
  • [38] CDK4/6 Inhibitors in the Treatment of Metastatic Breast Cancer
    Ettl, Johannes
    Huober, Jens
    Lueftner, Diana
    Marme, Frederik
    Wuerstlein, Rachel
    BREAST CARE, 2017, 12 (02) : 118 - 120
  • [39] Effect of CDK4/6 Inhibitors on Tumor Immune Microenvironment
    Liu, Jie
    Cheng, Min
    Xu, Jiamei
    Liang, Yue
    Yin, Beibei
    Liang, Jing
    IMMUNOLOGICAL INVESTIGATIONS, 2024, 53 (03) : 437 - 449
  • [40] CDK4/6 Inhibitors Represent Potential Psoriasis Therapeutics
    Brownell, I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (11) : 2098 - 2098
12345